Market Insights
Big News! Excited to share that Ankascin 568 has been selected as a finalist at the Vitafoods Europe Innovation Awards in the Healthy Ageing category.
We are thrilled to announce that we will be exhibiting at Vitafoods Europe this year in Barcelona!
We are thrilled to announce that we will be exhibiting at Making Nutraceuticals this year in Conventry!
We are thrilled to announce that we will be exhibiting at #SupplySideGlobal this year in Las Vegas!
We’re proud to announce that our flagship probiotic strain — Lactobacillus paracasei NTU 101, marketed as #Vigiis101 — has officially received GRAS (Generally Recognized As Safe) status, GRN 001232, from the U.S. Food and Drug Administration (FDA). This is the first-ever GRAS recognition for L. paracasei from Taiwan, highlighting SunWay Biotech’s excellence in R&D and our strategic vision for the global probiotic market.
SunWay's groundbreaking psychobiotic innovation, ExoBDNF®, took center stage at the prestigious Cognition Insight Forum on June 8th. Dr. Shih, our esteemed R&D Manager, captivated an enthusiastic audience of over 60 leading psychiatrists and family medicine practitioners, igniting engaging discussions about probiotics' transformative potential on gut-brain health and cognitive function.
Have you noticed the rising interest in brain health supplements lately? It’s no longer just older adults who are looking for cognitive support—today, students aiming for peak exam performance, busy professionals needing sharp focus, gamers wanting quick reflexes, and athletes seeking enhanced mental stamina are all joining the trend.
Despite the pharmaceutical advancements in weight management, the demand for natural supplements continues to soar. According to Nutrition Business Journal, the weight management sector is expected to reach $8.7 billion by 2027, proving that consumers still value holistic approaches.
The first clinical study, which has been published in Heliyon, documents that Vigiis® 101-LAB significantly increases the bacterial counts of Bifidobacterium spp. and Lactobacillus spp. in feces in just one week, and maintains those elevated counts for four weeks.
The regulatory landscape for red yeast rice (RYR) is undergoing significant change. With growing concerns about monacolin K, the European Food Safety Authority (EFSA) NDA Panel has raised serious safety alerts—even at very low intake levels. As stricter regulations are anticipated, it is imperative for the nutraceutical industry to proactively transition toward safer, regulation-friendly alternatives.